Lantern Pharma Inc. (LTRN) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -3.77M | -2.79M | -4.57M | -3.94M | -4.38M | -3.97M | -5.58M | -5.19M | -3.07M | -3.39M | -3.61M | -3.59M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 13.78% | 29.7% | 18.1% | 24.15% | -42.6% | -17.32% | -54.54% | -44.51% | 18.33% | -26.85% | 10.55% | -31.45% |
| Net Income | -3.33M | -4.07M | -4.18M | -4.33M | -4.54M | -5.88M | -4.51M | -4.96M | -5.44M | -4.19M | -3.16M | -4.75M |
| Depreciation & Amortization | 3.85K | 4.1K | 4.1K | 4.5K | 4.57K | 51.22K | 4.39K | 46.27K | 45.14K | 44.32K | 3.71K | 43.76K |
| Stock-Based Compensation | 0 | 198.82K | 143.69K | 160.63K | 147.75K | 285.5K | 179.17K | 134.17K | 134.06K | 150.84K | 190.75K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 180.44K | 95.5K | 0 |
| Other Non-Cash Items | 316.04K | 238.1K | 114.44K | -153.27K | -60.25K | 253.38K | -345.76K | -109.92K | 62.25K | -454.25K | 39.61K | 431.32K |
| Working Capital Changes | -763.35K | 841.08K | -656.78K | 381.88K | 69.09K | 1.31M | -914.35K | -301.64K | 2.13M | 879.22K | -780.24K | 679.39K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -705.02K | 0 | -806.92K | 627.28K | -15.55K | 737.88K | -1.03M | 661.18K | 1.27M | 419.92K | -767.87K | 179.07K |
| Cash from Investing | 4.25M | -1.7M | 5.93M | 3.59M | 3.24M | 3.45M | 680.35K | -202.06K | -556.17K | 256.18K | 231.73K | -457.24K |
| Capital Expenditures | 0 | -1 | -555 | 0 | -1.16K | -3.08K | -3.03K | -4.27K | -2.22K | -5.08K | -4.78K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -261 | -236 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 17.41M | 0 | 0 | 261 | 236 | 0 |
| Cash from Financing | 0 | 526.46K | 971.78K | 0 | 0 | 0 | 11.99K | 0 | 54.72K | -500K | 0 | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 666.21K | 971.78K | 0 | 0 | 0 | 11.99K | 0 | 54.72K | -500K | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -500K | 0 | 0 |
| Other Financing | 0 | -139.75K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 494.96K | -3.97M | 2.33M | -316.19K | -1.13M | -591.74K | -4.87M | -5.38M | -3.58M | -3.63M | -3.39M | -4.06M |
| Free Cash Flow | -3.77M | -2.79M | -4.57M | -3.94M | -4.38M | -3.97M | -5.59M | -5.19M | -3.07M | -3.39M | -3.62M | -3.59M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 13.8% | 29.76% | 18.13% | 24.21% | -42.53% | -17.24% | -54.42% | -44.63% | 18.46% | -26.71% | 10.58% | -30.77% |
| FCF per Share | -0.34 | -0.26 | -0.42 | -0.37 | -0.41 | -0.37 | -0.52 | -0.48 | -0.29 | -0.31 | -0.33 | -0.33 |
| FCF Conversion (FCF/Net Income) | 1.13x | 0.69x | 1.09x | 0.91x | 0.96x | 0.68x | 1.24x | 1.05x | 0.56x | 0.81x | 1.14x | 0.76x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |